Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Demecolcine results in increased expression of GPATCH2L mRNA | CTD | PMID:23649840 | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GPATCH2L mRNA | CTD | PMID:36331819 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Gpatch2l (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of GPATCH2L mRNA | CTD | PMID:22298810 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Gpatch2l (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GPATCH2L mRNA | CTD | PMID:36041667 | acrolein | multiple interactions | ISO | GPATCH2L (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of GPATCH2L mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of GPATCH2L mRNA | CTD | PMID:32699268 | aflatoxin B1 | increases methylation | ISO | GPATCH2L (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of GPATCH2L gene | CTD | PMID:27153756 | alpha-pinene | multiple interactions | ISO | GPATCH2L (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of GPATCH2L mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of GPATCH2L mRNA | CTD | PMID:32699268 | antirheumatic drug | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of GPATCH2L mRNA | CTD | PMID:24449571 | Benoxacor | increases expression | EXP | | 6480464 | benoxacor results in increased expression of GPATCH2L mRNA | CTD | PMID:34850242 | benzo[a]pyrene | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of GPATCH2L mRNA | CTD | PMID:20106945 and PMID:21632981 | benzo[a]pyrene | affects methylation | ISO | GPATCH2L (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of GPATCH2L promoter | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20018196 | bisphenol A | decreases expression | ISO | Gpatch2l (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of GPATCH2L mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | ISO | Gpatch2l (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GPATCH2L mRNA | CTD | PMID:36041667 | bisphenol F | multiple interactions | ISO | Gpatch2l (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GPATCH2L mRNA | CTD | PMID:36041667 | bortezomib | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Bortezomib results in increased expression of GPATCH2L mRNA | CTD | PMID:20977926 | caffeine | affects phosphorylation | ISO | GPATCH2L (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of GPATCH2L protein | CTD | PMID:35688186 | clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of GPATCH2L mRNA | CTD | PMID:23811191 | copper(II) sulfate | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of GPATCH2L mRNA | CTD | PMID:19549813 | coumestrol | decreases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Coumestrol results in decreased expression of GPATCH2L mRNA | CTD | PMID:19167446 | cyclosporin A | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of GPATCH2L mRNA | CTD | PMID:25562108 | dichloroacetic acid | increases expression | EXP | | 6480464 | Dichloroacetic Acid results in increased expression of GPATCH2L mRNA | CTD | PMID:28962523 and PMID:34850242 | dorsomorphin | multiple interactions | ISO | GPATCH2L (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPATCH2L mRNA | CTD | PMID:27188386 | epoxiconazole | increases expression | EXP | | 6480464 | epoxiconazole results in increased expression of GPATCH2L mRNA | CTD | PMID:35436446 | ethanol | affects splicing | EXP | | 6480464 | Ethanol affects the splicing of GPATCH2L mRNA | CTD | PMID:30319688 | ethyl methanesulfonate | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of GPATCH2L mRNA | CTD | PMID:23649840 | formaldehyde | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of GPATCH2L mRNA | CTD | PMID:23649840 | FR900359 | increases phosphorylation | ISO | GPATCH2L (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of GPATCH2L protein | CTD | PMID:37730182 | gentamycin | increases expression | ISO | Gpatch2l (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of GPATCH2L mRNA | CTD | PMID:33387578 | irinotecan | decreases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Irinotecan analog results in decreased expression of GPATCH2L mRNA | CTD | PMID:18927307 | leflunomide | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | leflunomide results in increased expression of GPATCH2L mRNA | CTD | PMID:28988120 | methoxychlor | affects methylation | ISO | Gpatch2l (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of GPATCH2L gene | CTD | PMID:35440735 | methyl methanesulfonate | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of GPATCH2L mRNA | CTD | PMID:23649840 | methylmercury chloride | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of GPATCH2L mRNA | CTD | PMID:28001369 | methylmercury chloride | decreases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of GPATCH2L mRNA | CTD | PMID:28001369 | nickel sulfate | decreases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of GPATCH2L mRNA | CTD | PMID:16780908 | ozone | multiple interactions | ISO | GPATCH2L (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of GPATCH2L mRNA more ... | CTD | PMID:32699268 | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of GPATCH2L mRNA | CTD | PMID:34911549 | paracetamol | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of GPATCH2L mRNA | CTD | PMID:21420995 | paracetamol | increases expression | ISO | Gpatch2l (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of GPATCH2L mRNA | CTD | PMID:33387578 | pentanal | decreases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | pentanal results in decreased expression of GPATCH2L mRNA | CTD | PMID:26079696 | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GPATCH2L mRNA | CTD | PMID:36331819 | poly(I:C) | multiple interactions | ISO | Gpatch2l (Rattus norvegicus) | 6480464 | [Poly I-C co-treated with HU 211] results in decreased expression of GPATCH2L mRNA | CTD | PMID:26923065 | quercetin | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Quercetin results in increased expression of GPATCH2L mRNA | CTD | PMID:21632981 | SB 431542 | multiple interactions | ISO | GPATCH2L (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPATCH2L mRNA | CTD | PMID:27188386 | trichostatin A | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | trichostatin A results in increased expression of GPATCH2L mRNA | CTD | PMID:26272509 | trichostatin A | multiple interactions | ISO | GPATCH2L (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPATCH2L mRNA | CTD | PMID:27188386 | urethane | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Urethane results in increased expression of GPATCH2L mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of GPATCH2L mRNA | CTD | PMID:23179753 | valproic acid | affects expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Valproic Acid affects the expression of GPATCH2L mRNA | CTD | PMID:25979313 | vincristine | increases expression | ISO | GPATCH2L (Homo sapiens) | 6480464 | Vincristine results in increased expression of GPATCH2L mRNA | CTD | PMID:23649840 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
